<DOC>
	<DOCNO>NCT01836757</DOCNO>
	<brief_summary>To delineate effect MSM osteoarthritis</brief_summary>
	<brief_title>Effect Methyl-Sulphonyl-Methane Osteoarthritis Cartilage</brief_title>
	<detailed_description>Objective : To delineate effect MSM osteoarthritis large joint . Design : Randomized , double-blind , placebo-controlled trial include intervention placebo group . One hundred men woman , hip and/or knee OA divide 2 group . Intervention either MSM 3 gr twice day 26 week ( 6 gr/day total ) one group placebo . Outcomes measured Western Ontario McMaster University Osteoarthritis Index visual analogue scale ( WOMAC ) , patient physician assessment SF-36 ( overall health-related quality life ) .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Dimethyl sulfone</mesh_term>
	<mesh_term>Dimethyl Sulfoxide</mesh_term>
	<criteria>Knee hip OA men woman &gt; 45 year age type arthritis chronic pain syndrome arthroscopic surgery past 8 month intraarticular corticosteroidsin past 8 month hyaluronic acid injection past 8 month narcotic pain killer use renal hepatic disease body mass index ( BMI ) &gt; 45 kg/m2 cancer</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>CAM treatment</keyword>
	<keyword>MSM</keyword>
</DOC>